y 27632 has been researched along with Fatty Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, H; Hirata, K; Kimura, Y; Kobayashi, T; Kuroda, S; Mikuriya, Y; Ohdan, H; Tanaka, Y; Tashiro, H; Tsutada, M | 1 |
Hibi, T; Horikawa, H; Ishii, H; Kitamura, K; Kumagai, N; Kurita, S; Nakamoto, N; Saito, H; Tada, S; Toda, K; Tsunematsu, S | 1 |
2 other study(ies) available for y 27632 and Fatty Liver
Article | Year |
---|---|
Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats.
Topics: Amides; Animals; Arterial Pressure; Cells, Cultured; Chemistry, Pharmaceutical; Choline Deficiency; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Hepatic Stellate Cells; Hypotension; Liposomes; Liver; Liver Circulation; Male; Portal Pressure; Protein Kinase Inhibitors; Pyridines; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases; Time Factors | 2015 |
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Choline Deficiency; Disease Models, Animal; DNA Damage; Fatty Liver; Liver; Liver Cirrhosis; Male; Organ Size; Oxidative Stress; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Tetrazoles; Time Factors; Tumor Necrosis Factor-alpha | 2007 |